Oregon's health department has rewritten its official take on cannabis. The Oregon Health Authority (OHA) released a 20-page report, *Health Effects of Cannabis: Public Health Statements*, its first major update since 2017, The Marijuana Herald reports.
The report sorts hundreds of studies into five evidence levels. OHA found moderate or strong evidence of benefit for:
- Chronic pain in adults, though gains are generally modest and strongest for oral or under-the-tongue cannabinoid products
- Seizures linked to Dravet syndrome, Lennox-Gastaut syndrome and tuberous sclerosis complex, mostly based on pharmaceutical CBD like Epidiolex
- Multiple sclerosis muscle spasticity
- Chemotherapy nausea and vomiting, using pharmaceutical THC
Evidence for anxiety, PTSD and neuropathic pain was called insufficient or conflicting, and sleep findings were mixed, with signs that long-term use may worsen sleep.
The report is not one-sided. OHA lists moderate or strong evidence linking cannabis use to higher risk of heart attack and stroke, ties heavy smoking to chronic bronchitis, and notes associations with psychosis, especially for teens, frequent users and high-THC products. It also covers driving impairment, pregnancy and kids' accidental exposure.
What it means for travelers: It's a solid, plain-language reality check before you shop in Oregon. Start low, keep products away from kids, and never drive after consuming.






